Change Location × Los Angeles

    Find Me

    • Use Current Location

    Recent Locations

      “Tumor-infiltrating Myeloid Cells Contribute to Treatment Failure in Prostate Cancer” in Los Angeles

      • “Tumor-infiltrating Myeloid Cells Contribute to Treatment Failure in Prostate Cancer” Photo #1
      1 of 1
      November 29, 2012

      Thursday  12:00 PM - 1:00 PM

      UCLA Campus
      Los Angeles, California 90024

      Map
      Performers:
      • No Performers Listed
      0 people track this event
      EVENT DETAILS
      “Tumor-infiltrating Myeloid Cells Contribute to Treatment Failure in Prostate Cancer”

      Thursday, November 29, 2012
      12:00 pm - 1:00 pm, Health Sciences Ctr. - Room 73-105

      Lily Wu, Ph.D.

      See below for additional information.

      Admission

      Free and open to the public.Contact

      Jonsson Comprehensive Cancer Center
      (310) 825-5268
      ajun@mednet.ucla.eduAdditional Information

      Presented by: Lily Wu, Ph.D., Professor, Department of Molecular & Medical Pharmacology

      Dr. Lily Wu's research is aimed at developing a better understanding of cancer biology and improving gene-based therapy. She and her colleagues have utilized the efficient gene transfer property of adenovirus to create tissue-targeted therapy for cancer. By applying this targeted gene-expression approach to molecular imaging, metastatic lesions were detected in living tumor-bearing mice. To gain a better understanding of metastasis, the advanced and deadly stage of cancer, she and her colleagues are actively investigating tumor blood and lymphatic vasculatures that serve as routes of tumor cell spread. A variety of therapeutic approaches are being implemented in prostate and breast cancer models. In one strategy, they are modifying adenovirus and herpes virus to mediate cancer-specific lysis. Molecular imaging techniques such as optical charge-coupled devices (CCD) imaging and positron emission tomography (PET) are fundamental tools of their investigation. Wu's ultimate goal is to create potent and effective cancer-targeted therapy to diagnose and treat advanced stage and metastatic cancer.

      *Light lunch served.

      Categories: University & Alumni

      Event details may change at any time, always check with the event organizer when planning to attend this event or purchase tickets.
      COMMENTS ABOUT “Tumor-infiltrating Myeloid Cells Contribute to Treatment Failure in Prostate Cancer”